Yubo International Biotech Limited Stock Other OTC
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | 0.1 | Sales 2023 | 0.6 | Capitalization | 35.95M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | 116,560,264 x |
Net Debt 2022 | 772K | Net Debt 2023 | 386K | EV / Sales 2023 | 60,084,725 x |
P/E ratio 2022 |
-9.36
x | P/E ratio 2023 |
-30.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 6.63% |
Managers | Title | Age | Since |
---|---|---|---|
Jun Wang
CEO | Chief Executive Officer | 57 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 19-12-31 |
1st Jan change | Capi. | |
---|---|---|
+27.45% | 48.16B | |
-0.88% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.54% | 25.59B | |
-22.83% | 18.96B | |
+8.00% | 12.92B | |
+29.29% | 12.03B | |
-2.07% | 11.77B |